Gerard Criner, MD
Temple Health · Temple University · Temple University School of Medicine, 3401 North Broad Street, Suite 745 PP, Philadelphia, PA 19140
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gerard Criner, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:48 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07051707 · Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDNuvaira, Inc. · recruiting · COPD, Chronic Obstructive Pulmonary Disease · principal investigator
- N/ANCT06933758 · Temple Health Chest Initiative (THCI 2.0)Temple University · recruiting · Chronic Obstructive Pulmonary Disease (COPD) · principal investigator
- N/ANCT06891755 · Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3Apreo Health, Inc. · recruiting · COPD, Emphysema · principal investigator
- N/ANCT05204875 · Functional Lung Imaging in Patients With Respiratory Compromise Undergoing Endobronchial Valve PlacementTemple University · unknown · Emphysema · principal investigator
- N/ANCT04302272 · STRIVE Post-Market Registry StudyOlympus Corporation of the Americas · recruiting · Emphysema · principal investigator
- Ph3NCT04053634 · Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsAstraZeneca · completed · Chronic Obstructive Pulmonary Disease · principal investigator
- N/ANCT03893370 · RejuvenAir® System Trial for COPD With Chronic BronchitisCSA Medical, Inc. · unknown · Chronic Bronchitis · principal investigator
- N/ANCT03030313 · Respiration Rate Monitoring in COPD PatientsResMed · completed · Pulmonary Disease, Chronic Obstructive · principal investigator
- Ph3NCT02138916 · Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryAstraZeneca · completed · Moderate to Very Severe Chronic Obstructive Pulmonary Disease · principal investigator
- N/ANCT01796392 · Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)Pulmonx Corporation · completed · Emphysema · principal investigator
- Ph2NCT00630227 · Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous StudyAeris Therapeutics · completed · Homogeneous Emphysema · principal investigator
- Ph2NCT00515164 · US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyAeris Therapeutics · completed · Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease · principal investigator
- Ph2NCT00435253 · US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyAeris Therapeutics · completed · Pulmonary Emphysema · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.